Effects of shRNA interfering hexokinase Ⅱ gene expression on the malignant biological behaviors of human lymphoma cells
Biyu XU,Xia SHAO,Yiwei ZHANG,Jiayi CAI,Fangyuan CHEN,Ting WANG
DOI: https://doi.org/10.3781/j.issn.1000-7431.2017.11.816
2017-01-01
Tumori
Abstract:Objective:To investigate the effects of hexokinase Ⅱ (HK Ⅱ) gene-silencing by shRNA interference on cell metabolism,proliferation,apoptosis and drug-resistance of human lymphoma cell lines Raji and SU-DHL-4,therefore to evaluate the potential value of HK Ⅱ gene-targeted therapy for the treatment of lymphoma.Methods:The lymphoma cell lines Raji and SU-DHL-4 transfected with lentiviral vectors carring shRNAs targeting HK Ⅱ gene (HK Ⅱ shRNA) were established,while the control vectors carring negative control shRNAs were used as the control group.The expression levels of HK Ⅱ mRNA and protein were detected by real-time fluorescent quantitative PCR and Western blotting,respectively.Then the cell viability was assessed using trypan blue staining,and the cell growth curve was drawn.The half maximal inhibitory concentration (IC50) of doxorubicin (DOX) for lymphoma cells was examined by CCK-8 method.The cell cycle distribution and apoptosis were analyzed by flow cytometry.The expression levels of apoptosis-related proteins caspase-3,cleaved caspase-3 (c-caspase-3),Bcl-2 and Bcl-6 were detected by Western blotting.The concentrations of lactic acid and glucose in the supernatant of cell culture were analyzed using Lactic Acid Detection Kit and Glucose (HK) Assay Kit,respectively.Results:Compared with the control group,the levels of HKⅡ mRNA and protein were significantly decreased in HK Ⅱ shRNA transfected Raji and SU-DHL-4 cells (all P ＜ 0.05).After HK Ⅱ gene-silencing by HK Ⅱ shRNA interference,the proliferation of lymphoma Raji and SU-DHL-4 cells was significantly inhibited (both P ＜ 0.01),the cell cycle was arrested in G0/G1 phase (both P ＜ 0.05),and the apoptosis was induced (both P ＜ 0.01).Compared with the control group,HK Ⅱ gene-silencing reduced IC50 value of DOX in lymphoma Raji and SU-DHL-4 cells (both P ＜ 0.05),inhibited glucose consumption (both P ＜ 0.05),and decreased lactic acid generation (both P ＜ 0.01).In HK Ⅱ shRNA transfected Raji and SU-DHL-4 cells,the level of Bcl-2 protein was down-regulated (both P ＜ 0.05),and the level of c-caspase-3 was up-regulated (both P ＜ 0.05).When the lymphoma Raji and SU-DHL-4 cells were treated with DOX (0.1 μmol/L),the level of Bcl-2 in HK Ⅱ shRNA transfection group was not significantly changed (both P ＞ 0.05),whereas the level of caspase-3 was obviously decreased (both P＜ 0.01),and the level of c-caspase-3 was significantly increased (both P ＜ 0.05) as compared with the control group.Conclusion:HK Ⅱ gene-silencing by shRNA interference can suppress the proliferation,promote the apoptosis,correct the glycolytic metabolism phenotype,and enhance the sensitivity of lymphoma cells to chemotherapeutic drug DOX.It suggests that HK Ⅱ gene may be a potential target for the treatment of relapsed aggressive lymphoma.